HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elacridar

inhibitor of MDR1 PROTEIN; structure given in first source
Also Known As:
GF 120918; GF-120918; GF120918; GF120918A; GG918; N-(4-(2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl)phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide
Networked: 96 relevant articles (7 outcomes, 23 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Beijnen, Jos H: 13 articles (01/2018 - 07/2003)
2. Elmquist, William F: 8 articles (01/2020 - 07/2010)
3. Schinkel, Alfred H: 6 articles (10/2015 - 04/2009)
4. Schellens, Jan H M: 5 articles (01/2018 - 10/2004)
5. van Tellingen, Olaf: 5 articles (01/2018 - 07/2003)
6. Langer, Oliver: 4 articles (01/2018 - 04/2011)
7. Mittapalli, Rajendar K: 4 articles (01/2016 - 04/2013)
8. Rosing, Hilde: 4 articles (10/2015 - 10/2004)
9. Agarwal, Sagar: 4 articles (04/2013 - 07/2010)
10. Sane, Ramola: 4 articles (04/2013 - 07/2010)

Related Diseases

1. Glioma (Gliomas)
2. Brain Neoplasms (Brain Tumor)
3. Neoplasms (Cancer)
4. Glioblastoma (Glioblastoma Multiforme)
5. Medulloblastoma

Related Drugs and Biologics

1. Gefitinib (Iressa)
2. veliparib
3. Imatinib Mesylate (Gleevec)
4. Dasatinib (BMS 354825)
5. Cyclin-Dependent Kinase Inhibitor p16
6. Vemurafenib
7. Temozolomide (Temodar)
8. Member 1 Subfamily B ATP Binding Cassette Transporter
9. Elacridar
10. Proteins (Proteins, Gene)

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Oral Administration